SEC v. Nutra Pharma Corp. et al (unregistered distributions, 2024)

Judgment entered

Checked against the primary document on October 2, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, with sampled and disputed records read a second time. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sec-nutra-pharma-corp-et-al-unregistered-distributions-2024) by email

In May 2024 final consent judgments were entered against Nutra Pharma CEO Rik Deitsch and consultant Sean McManus; Deitsch owes $44,046 disgorgement, $5,013 interest and a $30,000 penalty.

The record

Structured fields for this action, as recorded in our case library.
Agency	SEC
Release number	LR-26007
Date filed	2024-05-15
Date resolved	2024-05-15
Court	U.S. District Court, Eastern District of New York
Status	judgment
Asset class	equities
Criminal parallel	No
Bars imposed	officer-and-director bar, penny stock bar
Defendants	Rik Deitsch (individual) ; Sean McManus (individual)
Cited as charged or alleged	Exchange Act s.10(b) and Rule 10b-5 ; Exchange Act s.13(a) ; Exchange Act s.13(d) and 13(g) ; Exchange Act s.15(a) ; Exchange Act s.16(a) ; Exchange Act s.9(a)(2) ; Securities Act s.17(a) ; Securities Act s.5 (statutes and rules cited in the document; not a finding that they were violated)
Techniques	Unregistered distributions

What was ordered

Civil penalty: $30k
Disgorgement: $44k
Prejudgment interest: $5k
Total relief: $79.1k
Alleged gain: —

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars.

What is alleged to have happened

On May 15, 2024 the SEC announced final consent judgments entered May 13, 2024 against Rik Deitsch and Sean McManus in its Nutra Pharma case. Deitsch, charged with Securities Act Sections 5(a), 5(c) and 17(a) and other violations, was ordered to pay $44,046.28 in disgorgement, $5,013.49 in interest and $30,000 in penalties, with a three-year officer and director bar and penny stock bar; the court had granted summary judgment on his Section 5 violation in 2022. McManus owes $5,500 in disgorgement, $625.03 in interest and $5,500 in penalties, with a two-year penny stock bar. The figures recorded are Deitsch's. The record previously showed the status as dismissed and omitted the penalty.

This library tags the matter as unregistered distributions, based on the conduct the document describes. The tagging is ours, not the regulator's: agencies charge statutory provisions, not technique names.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the release.

What technique is this, and how does it work?

This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

Unregistered distributions — see how it works, what statute it engages, and every other action tagged the same way.

Timeline

2024-05-15 Litigation release published

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

SEC litigation release

The linked release is a work of the United States government and is not subject to copyright. Our summary and narrative above are our own writing.

Same matter

The library links these 4 records because they appear to concern one matter: the same lead defendant, an overlapping technique tag and close filing dates, or a shared court docket or a release that cites the other. Records are listed by date filed.

Date filed	Agency	Record	Status
2018-09-28	SEC	SEC v. Nutra Pharma Corp. et al (unregistered distributions, 2018)	Settled
2022-09-16	SEC	SEC v. Nutra Pharma Corp. et al (unregistered distributions, 2022)	Judgment entered
2024-05-15	SEC	SEC v. Nutra Pharma Corp. et al (unregistered distributions, 2024)(this record)	Judgment entered
2024-08-30	SEC	SEC v. Nutra Pharma Corporation, et al. (unregistered distributions, 2024)	Judgment entered

This grouping is the library's, made by matching names, techniques, dates and citations when the site is built. It is not the regulator's or a court's determination that the records are one case, and it errs towards missing a link rather than making a false one.

Other actions in the library sharing at least one technique tag with this one.

Action	Agency	Filed	Technique	Penalty	Status
SEC v. Zachary Miller (unregistered distributions, 2026)	SEC	2026-03-05	Unregistered Distributions	—	settled
SEC v. David Hudzik (unregistered distributions, 2025)	SEC	2025-12-23	Unregistered Distributions	$70k	judgment
SEC v. Ongkaruck Sripetch and others (pump and dump, 2025)	SEC	2025-06-20	Pump And Dump , Unregistered Distributions	$204k	judgment
SEC v. Peter Scalise III and The3rdBevco Inc. (unregistered distributions, 2025)	SEC	2025-06-17	Unregistered Distributions	$236k	settled
SEC v. Investview, Inc. (unregistered distributions, 2025)	SEC	2025-01-17	Unregistered Distributions	$375k	settled
SEC v. Tai Mo Shan Limited (unregistered distributions, 2024)	SEC	2024-12-20	Unregistered Distributions	$36.7m	settled

Record added September 10, 2026. submit a correction.